Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis

Document Details

Document Type
Pub Defense Publication
Publication Date
Jun 01, 2018
Source ID
10.1016/j.canlet.2018.03.029

Entities

People

  • Dengfeng Li
  • Hong Wang
  • Hyejin Kim
  • Jia Zhou
  • Jiabin Dong
  • Lin Fang
  • Qiang Shen
  • Qianjun Zhou
  • Xiaojing Meng
  • Ye Ding
  • Zhi Zheng
  • Ziwei Zhang

Organizations

  • China Scholarship Council
  • Duncan Family Institute for Cancer Prevention and Risk Assessment
  • Prevent Cancer Foundation
  • The University of Texas MD Anderson Cancer Center
  • United States Department of Defense